Table 1.
Diagnosis (n = 459) |
6 weeks post-treatment (n = 396) |
6 months post-treatment (n = 348) |
12 months post-treatment (n = 287) | 24 months post-treatment (n = 208) | |
---|---|---|---|---|---|
Sex (male) [n (%)] | 303 (66.0) | 270 (68.2) | 236 (67.8) | 196 (68.3) | 142 (68.3) |
Age (years) [mean (SD)] | 66.9 (9.1) | 67.0 (9.1) | 67.2 (9.23) | 67.4 (9.2) | 68.1 (9.2) |
Education [n (%)] | |||||
Low | 130 (29.0) | 107 (27.1) | 91 (26.2) | 73 (25.5) | 45 (21.6) |
Medium | 168 (37.4) | 149 (37.7) | 137 (39.5) | 114 (39.9) | 89 (42.8) |
High | 151 (33.6) | 139 (35.2) | 119 (34.3) | 99 (34.6) | 74 (34.6) |
Comorbidities [n (%) | |||||
0 co-morbidities | – | 91 (23.0) | 88 (25.4) | 71 (25.1) | 46 (22.6) |
1 comorbidity | – | 102 (25.8) | 87 (25.1) | 64 (22.6) | 49 (24.0) |
≥ 2 co-morbidities | – | 202 (51.1) | 172 (49.6) | 148 (52.3) | 109 (53.4) |
Smoking [n (%)] | |||||
Never | 139 (31.0) | 118 (30.5) | 98 (28.7) | 76 (27.6) | 57 (29.1) |
Former | 255 (56.8) | 235 (60.7) | 213 (62.5) | 172 (62.6) | 120 (61.2) |
Current | 55 (12.3) | 34 (8.8) | 30 (8.8) | 27 (9.8) | 19 (9.7) |
Body mass index, kg/m2 [mean (SD)] | 28.3 (4.7) | 27.8 (4.6) | 28.3 (4.7) | 28.7 (4.8) | 28.3 (4.6) |
Underweight: < 18.5 | 2 (0.4) | 2 (0.5) | 0 (0.0) | 1 (0.4) | 1 (0.5) |
Healthy weight: 18.5–24.9 | 111 (24.3) | 117 (29.6) | 90 (25.9) | 62 (21.9) | 49 (24.0) |
Overweight: 25–29.9 | 201 (44.0) | 173 (43.8) | 151 (43.5) | 130 (45.9) | 85 (41.7) |
Obese: ≥ 30 | 143 (31.3) | 103 (26.1) | 106 (30.6) | 90 (31.8) | 69 (33.8) |
Waist circumference, cm [mean (SD)] | 101.5 (13.6) | 100.1 (12.9) | 101.3 (13.4) | 102.3 (13.2) | 101.7 (13.1) |
Fat percentage, % [mean (SD)] | 33.6 (6.4) | 32.9 (6.4) | 33.4 (6.2) | 33.9 (6.3) | 33.6 (6.3) |
MUAMC, mm [mean (SD)] | 249.1 (29.6) | 247.7 (28.1) | 250.8 (29.6) | 253.1 (28.0) | 253.7 (29.4) |
Handgrip strength, kg [mean (SD)] | 38.1 (12.0) | 36.3 (11.7) | 37.0 (11.8) | 37.5 (12.4) | 36.9 (12.4) |
Total sedentary time, hours/week [mean (SD)] | 10.8 (1.8) | 10.1 (1.5) | 10.2 (1.5) | 10.2 (1.4) | |
Prolonged sedentary time. hours/week [mean (SD)] | – | 5.3 (2.7) | 4.2 (1.9) | 4.4 (1.9) | 4.5 (1.9) |
Light physical activity, minutes/week [median (IQR)] | 660 (1350) | 450 (930) | 630 (1080) | 630 (1080) | 630 (1080) |
Moderate-to-vigorous physical activity. minutes/week [median (IQR)] | 660 (780) | 420 (645) | 570 (660) | 600 (750) | 600 (760) |
Adherence to physical activity recommendation (yes) [n (%)] | 408 (90.9) | 320 (82.0) | 302 (87.5) | 255 (90.1) | 181 (90.5) |
Tumor stage [n (%)] | |||||
Stage I | 141 (30.7) | 124 (31.3) | 109 (31.3) | 97 (33.8) | 71 (34.1) |
Stage II | 108 (23.5) | 100 (25.3) | 86 (24.7) | 69 (24.0) | 52 (25.0) |
Stage III | 210 (45.8) | 172 (43.4) | 153 (44.0) | 121 (42.2) | 85 (40.9) |
Cancer type [n (%)] | |||||
Colon | 290 (63.2) | 250 (63.1) | 222 (63.8) | 181 (63.1) | 126 (60.6) |
Rectosigmoid and rectum | 169 (36.8) | 146 (36.9) | 126 (36.2) | 106 (36.9) | 82 (39.4) |
Treatment [n (%)] | |||||
Surgery (yes) | 412 (89.8) | 354 (89.4) | 317 (91.1) | 259 (90.2) | 186 (89.4) |
Chemotherapy (yes) | 184 (40.1) | 155 (39.1) | 134 (38.5) | 107 (37.3) | 79 (38.0) |
Radiotherapy (yes) | 116 (25.3) | 101 (25.5) | 88 (25.3) | 73 (25.4) | 55 (26.4) |
Stoma (yes) [n (%)] | 3 (0.7) | 110 (28.4) | 68 (19.8) | 43 (15.2) | 26 (13.1) |
BMI body mass index, MUAMC mid-upper arm muscle circumference, SD standard deviation, wk week
aPercentages may not add to 100 due to rounding
dFor accelerometer data n = 32